Dr. Carl Spengler

Dr. Carl Spengler the discoverer and founder of the Spenglersan Immuntherapie

Carl Spengler was born 1860 in Davos as a son of Dr. Alexander Spengler (Alexander house). After its license to practise medicine to the Dr. med. he worked in practice its father in Davos. In this time it published several papers over the Tuberculosis. Robert Koch became therefore attentive to him and got him as a coworker to Berlin into his Institut. There Spengler co-operated among other things with the Nobelpreisträgern of Behring and Kitasato.
During his work with Robert Koch at its Tuberkulin discovered Spengler the meaning of the Mix infects. 1895 handed over to Koch its original Tuberculin Carl Spengler Robert to extensive bakteriological research. This resumed Spengler in Davos apart from its practical medical activity.
Spengler looked for new therapeutic ways to the treatment of the Tuberculosis. The IK-preparations manufactured by it (IK= immune body) formed the basis of its large therapeutic successes. Spengler could state that the IK-preparations were in high dilute however strongly effective in concentrated form weakly. At first these IK-preparations were brought subcutaneous, later percutaneously to application. 1904 were made into the DMW a publication by it, 1911 appeared his “Tuberculosis and Syphilis work”. Later still work followed over its cancer research.
Main earnings/services of Spenglers are based certainly in the fact that it recognized the meaning of the Mix infects, which made the treatment more difficult of the Tuberculosis as one of the first researchers correctly as well as as “masked their meaning for the total organism Tuberculosis”.
Outgoing from this realization, Spengler came with the advancement of its colloid therapy on the ingenious thought at the same time to accomplish the active Immunization with a passive which still work also there and could help, where the active Immunization had to fail due to the weakened defense protection against the organism.
This colloid used with large success to the Tuberculosis treatment was called later “Spenglersan colloid T”.
Due to the unusually good experiences with the “colloid T” Spengler developed gradually a set of further mixing colloids, which cover a large circle of infections. How very much Spengler met with it the correct, successes prove with symptoms, which defied frequently different therapies. In all cases so far predominantly the symptoms were fought, this temporarily brought to disappearing, the actual (masked) cause remained however uninfluenced.
Dr. Carl Spengler was however not only a scientist and a physician of first rank, as a sportsman stepped out he exactly the same. In order to unite and the mutual understanding and confidence promote by sporty establishment of contact the nations disliked by the First World War again, it donated Christmas 1923 to the “Spengler Cup”. Since that time around this desired ice hockey Trophies (with short interruptions) each year in Davos an international tournament is delivered.
Briefly before its death Carl Spengler transferred 1937 at Paul A. Meckel, its coworker and later founder of the company Meckel, exclusive the rights to distribute and manufacture of all of its prescriptions and medicaments as well as the entire scientific deduction.
This original documents today Meckel are at the Meckel Spenglersan GmbH as a right successor of the company.